Cite
Pratt AG, Siebert S, Cole M, et al. Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial. Lancet Rheumatol. 2021;3(5):e337-e346doi: 10.1016/S2665-9913(21)00061-8.
Pratt, A. G., Siebert, S., Cole, M., Stocken, D. D., Yap, C., Kelly, S., Shaikh, M., Cranston, A., Morton, M., Walker, J., Frame, S., Ng, W. F., Buckley, C. D., McInnes, I. B., Filer, A., & Isaacs, J. D. (2021). Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial. The Lancet. Rheumatology, 3(5), e337-e346. https://doi.org/10.1016/S2665-9913(21)00061-8
Pratt, Arthur G, et al. "Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial." The Lancet. Rheumatology vol. 3,5 (2021): e337-e346. doi: https://doi.org/10.1016/S2665-9913(21)00061-8
Pratt AG, Siebert S, Cole M, Stocken DD, Yap C, Kelly S, Shaikh M, Cranston A, Morton M, Walker J, Frame S, Ng WF, Buckley CD, McInnes IB, Filer A, Isaacs JD. Targeting synovial fibroblast proliferation in rheumatoid arthritis (TRAFIC): an open-label, dose-finding, phase 1b trial. Lancet Rheumatol. 2021 Mar 09;3(5):e337-e346. doi: 10.1016/S2665-9913(21)00061-8. eCollection 2021 May. PMID: 33928262; PMCID: PMC8062952.
Copy
Download .nbib